Print Issue: July 01, 2007

Botox Better Than Expected

Botox Better Than Expected

ANAHEIM, Calif.—Just one injection of botulinum toxin type A (Botox) into the prostate may provide relief from BPH-related lower urinary tract symptoms (LUTS) for up to 12 months.

Beta Blocker Controls BP Long Term

CHICAGO—A novel beta blocker under FDA review controls BP long term without the adverse effects associated with first-generation beta blockers, according to data presented here at the 22nd Annual Scientific Meeting of the American Society of Hypertension.

Angioplasty Shown to Preserve Limbs

SEATTLE—Percutaneous transluminal angioplasty (PTA) safely treats infragenicular arterial disease and helps to preserve limbs, according to a study presented here at the Society of Interventional Radiology annual meeting.

Watchful Waiting Risks Quantified

ANAHEIM, Calif.—Fifteen percent of older men managed with watchful waiting for low-risk prostate tumors detected by PSA screening will die from the malignancy in 10 years, despite a high death rate from competing causes, a study found.

The Case for Adjuvant PCa Treatment

With widespread screening now the norm, prostate cancer is being detected with increasing frequency and at earlier stages than in previous years. At least 90% of cases are metastasis-free at diagnosis and most patients undergo local treatment. Patients with locally advanced disease, however, are at high risk of recurrence and thus are more challenging to manage.

Stem Cells Work For Incontinence

ANAHEIM, Calif.—Women with stress urinary incontinence (SUI) injected with muscle-derived stem cells to strengthen their sphincter muscles experience long-term improvement, according to a small study.

Next post in News